BE788516A
(fr)
|
1971-09-10 |
1973-03-07 |
Lonza Ag |
Procede de fabrication d'esters alcoxyacetylacetiques
|
GB1528382A
(en)
|
1974-12-26 |
1978-10-11 |
Teijin Ltd |
Cyclopentene diols and acyl esters thereof and processes for their preparation
|
DE2658401A1
(de)
|
1976-12-23 |
1978-07-06 |
Merck Patent Gmbh |
Cyclopentan-1-amine, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
|
US4575694A
(en)
|
1984-03-05 |
1986-03-11 |
Allied Corporation |
Coaxial connector
|
DE3900736A1
(de)
|
1989-01-12 |
1990-07-26 |
Hoechst Ag |
Positiv arbeitendes strahlungsempfindliches gemisch enthaltend einen mehrfunktionellen (alpha)-diazo-(beta)-ketoester, verfahren zu dessen herstellung und strahlungsempfindliches aufzeichnungsmaterial enthaltend dieses gemisch
|
US6703396B1
(en)
|
1990-02-01 |
2004-03-09 |
Emory University |
Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
|
US5204466A
(en)
|
1990-02-01 |
1993-04-20 |
Emory University |
Method and compositions for the synthesis of bch-189 and related compounds
|
US5914331A
(en)
|
1990-02-01 |
1999-06-22 |
Emory University |
Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
|
DE4014649A1
(de)
|
1990-05-08 |
1991-11-14 |
Hoechst Ag |
Neue mehrfunktionelle verbindungen mit (alpha)-diazo-ss-ketoester- und sulfonsaeureester-einheiten, verfahren zu ihrer herstellung und deren verwendung
|
GB9301000D0
(en)
|
1993-01-20 |
1993-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
US5922695A
(en)
|
1996-07-26 |
1999-07-13 |
Gilead Sciences, Inc. |
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
|
SE9702772D0
(sv)
|
1997-07-22 |
1997-07-22 |
Astra Pharma Prod |
Novel compounds
|
US5935946A
(en)
|
1997-07-25 |
1999-08-10 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
WO1999025345A1
(en)
|
1997-11-14 |
1999-05-27 |
Merck & Co., Inc. |
Alpha-1a adrenergic receptor antagonists
|
AU1061500A
(en)
|
1998-11-09 |
2000-05-29 |
James Black Foundation Limited |
Gastrin and cholecystokinin receptor ligands
|
GB2345058A
(en)
|
1998-12-01 |
2000-06-28 |
Cerebrus Pharm Ltd |
Hydroxypyridone compounds useful in the treatment of oxidative damage to the central nervous system
|
HUP0201472A3
(en)
|
1998-12-25 |
2006-03-28 |
Shionogi & Co |
Aromatic heterocycle compounds having hiv integrase inhibiting activities
|
US20040039060A1
(en)
|
2000-06-14 |
2004-02-26 |
Ryuichi Kiyama |
Inhibitor for enzyme having two divalent metal ions as active centers
|
JP4338192B2
(ja)
|
2001-08-10 |
2009-10-07 |
塩野義製薬株式会社 |
抗ウイルス剤
|
NZ532018A
(en)
|
2001-10-03 |
2004-12-24 |
Ucb S |
Pyrrolidinone derivatives
|
ATE318140T1
(de)
|
2001-10-26 |
2006-03-15 |
Angeletti P Ist Richerche Bio |
N-substituierte hydroxypyrimidinoncarboxamid- hemmer der hiv-integrase
|
WO2003042176A1
(fr)
|
2001-11-13 |
2003-05-22 |
Shiseido Co., Ltd. |
Compose azabicyclo, inhibiteur de metalloprotease matricielle et preparation cutanee
|
US7109186B2
(en)
|
2002-07-09 |
2006-09-19 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
CA2498111A1
(en)
|
2002-09-11 |
2004-03-25 |
Merck & Co., Inc. |
Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors
|
CZ2004764A3
(cs)
|
2002-11-20 |
2005-02-16 |
Japan Tobacco Inc |
4-Oxochinolinová sloučenina a její použití jako inhibitoru HIV-integrázy
|
EP3025718A1
(en)
|
2003-01-14 |
2016-06-01 |
Gilead Sciences, Inc. |
Compositions and methods for combination antiviral therapy
|
TW200510425A
(en)
|
2003-08-13 |
2005-03-16 |
Japan Tobacco Inc |
Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
|
TW200528440A
(en)
|
2003-10-31 |
2005-09-01 |
Fujisawa Pharmaceutical Co |
2-cyanopyrrolidinecarboxamide compound
|
CA2554120A1
(en)
|
2004-01-30 |
2005-08-18 |
Merck & Co., Inc. |
N-benzyl-3,4-dihydroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4-carboxamide compounds useful as hiv integras inhibitors
|
JP2007528396A
(ja)
|
2004-03-09 |
2007-10-11 |
メルク エンド カムパニー インコーポレーテッド |
Hivインテグラーゼ阻害薬
|
WO2005110399A2
(en)
|
2004-04-29 |
2005-11-24 |
The Regents Of The University Of California |
Zinc-binding groups for metalloprotein inhibitors
|
EP1755586A2
(en)
|
2004-04-29 |
2007-02-28 |
The Regents of the University of California |
Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors
|
EP1756114B1
(en)
|
2004-05-07 |
2014-11-19 |
Merck Sharp & Dohme Corp. |
Hiv integrase inhibitors
|
US7273859B2
(en)
|
2004-05-12 |
2007-09-25 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors: cyclic pyrimidinone compounds
|
MY134672A
(en)
|
2004-05-20 |
2007-12-31 |
Japan Tobacco Inc |
Stable crystal of 4-oxoquinoline compound
|
US7531554B2
(en)
|
2004-05-20 |
2009-05-12 |
Japan Tobacco Inc. |
4-oxoquinoline compound and use thereof as HIV integrase inhibitor
|
WO2005112930A1
(en)
|
2004-05-21 |
2005-12-01 |
Japan Tobacco Inc. |
Combinations comprising a 4-isoquinolone derivative and anti-hiv agents
|
WO2006030807A1
(ja)
|
2004-09-15 |
2006-03-23 |
Shionogi & Co., Ltd. |
Hivインテグラーゼ阻害活性を有するカルバモイルピリドン誘導体
|
CA2634499A1
(en)
|
2004-12-23 |
2006-06-29 |
Virochem Pharma Inc. |
Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase
|
WO2006088173A1
(ja)
|
2005-02-21 |
2006-08-24 |
Shionogi & Co., Ltd. |
Hivインテグラーゼ阻害活性を有する2環性カルバモイルピリドン誘導体
|
NZ562339A
(en)
|
2005-04-28 |
2011-01-28 |
Smithkline Beecham Corp |
Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity
|
TW200716632A
(en)
|
2005-05-16 |
2007-05-01 |
Gilead Sciences Inc |
Integrase inhibitor compounds
|
CA2616314A1
(en)
|
2005-07-27 |
2007-02-01 |
Gilead Sciences, Inc. |
Antiviral phosphonate conjugates for inhibition of hiv
|
TW200800988A
(en)
|
2005-10-27 |
2008-01-01 |
Shionogi & Amp Co Ltd |
Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity
|
SG170796A1
(en)
|
2005-12-30 |
2011-05-30 |
Gilead Sciences Inc Us |
Methods for improving the pharmacokinetics of hiv integrase inhibitors
|
US7601844B2
(en)
|
2006-01-27 |
2009-10-13 |
Bristol-Myers Squibb Company |
Piperidinyl derivatives as modulators of chemokine receptor activity
|
EP2452682A1
(en)
|
2006-02-01 |
2012-05-16 |
Japan Tobacco, Inc. |
Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection
|
CN101437801B
(zh)
|
2006-03-06 |
2013-02-06 |
日本烟草产业株式会社 |
制备4-氧代喹啉化合物的方法
|
IN2014CN00613A
(me)
|
2006-03-06 |
2015-08-21 |
Japan Tobacco Inc |
|
US7893055B2
(en)
|
2006-06-28 |
2011-02-22 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
MX2009000661A
(es)
|
2006-07-19 |
2009-03-27 |
Univ Georgia Res Found |
Piridinon-diceto-acidos: inhibidores de replicacion de vih en terapia de combinacion.
|
PL2057165T3
(pl)
|
2006-09-07 |
2011-08-31 |
Victoria Link Ltd |
Acykliczne inhibitory aminowe fosforylaz i hydrolaz nukleozydowych
|
BRPI0716752A2
(pt)
|
2006-09-12 |
2013-09-17 |
Gilead Sciences Inc |
processo e intermediÁrios para preparo de inibidores de intergrase
|
US20100216834A1
(en)
|
2006-10-18 |
2010-08-26 |
Isaacs Richard C A |
Hiv integrase inhibitors
|
MX2009008935A
(es)
|
2007-02-23 |
2009-11-02 |
Gilead Sciences Inc |
Moduladores de las propiedades farmacocineticas de productos terapeuticos.
|
US20080280945A1
(en)
|
2007-05-09 |
2008-11-13 |
Sachin Lohani |
Crystalline forms of an HIV integrase inhibitor
|
KR20100028656A
(ko)
|
2007-06-29 |
2010-03-12 |
길리애드 사이언시즈, 인코포레이티드 |
치료 조성물 및 그의 용도
|
AR067183A1
(es)
|
2007-06-29 |
2009-09-30 |
Gilead Sciences Inc |
Composiciones terapeuticas y metodos, usos y equipos
|
AU2008282273A1
(en)
|
2007-07-31 |
2009-02-05 |
Limerick Biopharma, Inc. |
Pyrone analog compositions and methods
|
AR068403A1
(es)
|
2007-09-11 |
2009-11-18 |
Gilead Sciences Inc |
Proceso e intermediarios para la preparacion de inhibidores de integrasa
|
UA100250C2
(uk)
|
2007-11-16 |
2012-12-10 |
Гілеад Сайнсіз, Інк. |
Інгібітори реплікації вірусу імунодефіциту людини
|
GB0803019D0
(en)
|
2008-02-19 |
2008-03-26 |
Btg Int Ltd |
Fluorinated compounds
|
US8129398B2
(en)
|
2008-03-19 |
2012-03-06 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
US20100272811A1
(en)
|
2008-07-23 |
2010-10-28 |
Alkermes,Inc. |
Complex of trospium and pharmaceutical compositions thereof
|
JP5586602B2
(ja)
|
2008-07-25 |
2014-09-10 |
ビーブ・ヘルスケア・カンパニー |
化合物
|
WO2010011819A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
ES2395705T3
(es)
|
2008-07-25 |
2013-02-14 |
Glaxosmithkline Llc |
Compuestos químicos
|
WO2010011815A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
WO2010011818A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
SI2320908T1
(sl)
|
2008-07-25 |
2014-05-30 |
Viiv Healthcare Company |
Predzdravila dolutegravirja
|
AU2009325128B2
(en)
|
2008-12-11 |
2015-01-29 |
Shionogi & Co., Ltd. |
Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates
|
KR101682058B1
(ko)
|
2008-12-11 |
2016-12-02 |
비이브 헬쓰케어 컴퍼니 |
카르바모일피리돈 hiv 인테그라제 억제제를 위한 제조방법 및 중간체
|
TWI518084B
(zh)
|
2009-03-26 |
2016-01-21 |
鹽野義製藥股份有限公司 |
哌喃酮與吡啶酮衍生物之製造方法
|
WO2010110231A1
(ja)
|
2009-03-26 |
2010-09-30 |
塩野義製薬株式会社 |
置換された3-ヒドロキシ-4-ピリドン誘導体
|
US8338441B2
(en)
|
2009-05-15 |
2012-12-25 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
LT2444400T
(lt)
|
2009-06-15 |
2018-06-11 |
Shionogi & Co., Ltd. |
Pakeistasis policiklinis karbamoilpiridono darinys
|
US8637674B2
(en)
|
2009-09-02 |
2014-01-28 |
Ewha University-Industry Collaboration Foundation |
Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same
|
AP3551A
(en)
|
2010-01-27 |
2016-01-18 |
Viiv Healthcare Co |
Antiviral therapy
|
KR20120130185A
(ko)
|
2010-02-26 |
2012-11-29 |
니뽄 다바코 산교 가부시키가이샤 |
1,3,4,8―테트라히드로―2H―피리도[1,2―a]피라진 유도체 및 그의 HIV 인테그라제 저해제로서의 이용
|
TWI582097B
(zh)
|
2010-03-23 |
2017-05-11 |
Viiv醫療保健公司 |
製備胺甲醯吡啶酮衍生物及中間體之方法
|
WO2011139637A1
(en)
|
2010-05-03 |
2011-11-10 |
Philadelphia Health & Education Corporation |
Small-molecule modulators of hiv-1 capsid stability and methods thereof
|
CA2802308C
(en)
|
2010-07-02 |
2018-08-28 |
Lianhong Xu |
Napht-2-ylacetic acid derivatives to treat aids
|
JP5806735B2
(ja)
|
2010-07-02 |
2015-11-10 |
ギリアード サイエンシーズ, インコーポレイテッド |
Hiv抗ウイルス化合物としての2−キノリニル−酢酸誘導体
|
WO2012009009A2
(en)
|
2010-07-14 |
2012-01-19 |
Addex Pharma S.A. |
Novel 2-amino-4-pyrazolyl-thiazole derivatives and their use as allosteric modulators of metabotropic glutamate receptors
|
ES2608377T3
(es)
|
2010-08-05 |
2017-04-10 |
Shionogi & Co., Ltd. |
Procedimiento de preparación de un compuesto que tiene actividad inhibidora de la integrasa del HIV
|
HUE039859T2
(hu)
|
2010-09-24 |
2019-02-28 |
Shionogi & Co |
Helyettesített policiklusos karbamoil-piridon-származék prodrug
|
WO2012106534A2
(en)
|
2011-02-02 |
2012-08-09 |
The Regents Of The University Of California |
Hiv integrase inhibitors
|
MX2013012266A
(es)
|
2011-04-21 |
2013-11-22 |
Gilead Sciences Inc |
Compuestos de benzotiazol y su uso farmaceutico.
|
US20140213553A1
(en)
|
2011-05-03 |
2014-07-31 |
Concert Pharmaceuticals Inc. |
Carbamoylpyridone derivatives
|
US9328075B2
(en)
|
2011-05-05 |
2016-05-03 |
St. Jude Children's Research Hospital |
Pyrimidinone compounds and methods for treating influenza
|
JP6205354B2
(ja)
|
2011-07-06 |
2017-09-27 |
ギリアード サイエンシーズ, インコーポレイテッド |
Hivの処置のための化合物
|
CN102863512B
(zh)
|
2011-07-07 |
2016-04-20 |
上海泓博智源医药技术有限公司 |
抗病毒化合物
|
US9206197B2
(en)
|
2011-09-14 |
2015-12-08 |
Mapi Pharma Ltd. |
Amorphous form of dolutegravir
|
AU2012321762A1
(en)
|
2011-10-12 |
2014-04-17 |
Shionogi & Co., Ltd. |
Polycyclic pyridone derivative having integrase-inhibiting activity
|
US9643974B2
(en)
|
2011-12-12 |
2017-05-09 |
Bayer Intellectual Property Gmbh |
Amino-substituted imidazopyridazines
|
MD20140063A2
(ro)
|
2012-04-20 |
2014-12-31 |
Gilead Sciences, Inc. |
Derivaţi de acid benzotiazol-6-il acetic şi utilizarea acestora pentru tratarea unei infecţii HIV
|
WO2014008636A1
(en)
|
2012-07-11 |
2014-01-16 |
Merck Sharp & Dohme Corp. |
Macrocyclic compounds as hiv integrase inhibitors
|
US20150166520A1
(en)
|
2012-07-20 |
2015-06-18 |
Merck Sharp & Dohme Corp. |
Amido-substituted pyrimidinone derivatives useful for the treatment of hiv infection
|
EP2877469A4
(en)
|
2012-07-25 |
2016-04-06 |
Merck Sharp & Dohme |
SUBSTITUTED NAPHTHYRIDINEDIONE DERIVATIVES AS INHIBITORS OF HIV INTEGRASE
|
AU2013296289B2
(en)
|
2012-08-03 |
2017-10-05 |
Gilead Sciences, Inc. |
Process and intermediates for preparing integrase inhibitors
|
BR112015009850A2
(pt)
|
2012-11-08 |
2017-07-11 |
Bristol Myers Squibb Co |
compostos de piridila substituídos por heteroarila úteis como moduladores de quinase
|
WO2014093941A1
(en)
|
2012-12-14 |
2014-06-19 |
Glaxosmithkline Llc |
Pharmaceutical compositions
|
US9714243B2
(en)
|
2012-12-17 |
2017-07-25 |
Merck Sharp & Dohme Corp. |
4-pyridinonetriazine derivatives as HIV integrase inhibitors
|
CA3012242C
(en)
|
2012-12-21 |
2021-11-02 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
US20140221355A1
(en)
|
2012-12-21 |
2014-08-07 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
EP2934482A4
(en)
|
2012-12-21 |
2016-07-20 |
Merck Sharp & Dohme |
ADMINISTRATIVE FORMULATIONS
|
SG11201504982PA
(en)
|
2012-12-27 |
2015-07-30 |
Japan Tobacco Inc |
SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND MEDICINAL USE THEREOF AS HIV INTEGRASE INHIBITOR
|
EP3008044B1
(en)
|
2013-06-13 |
2018-11-21 |
Merck Sharp & Dohme Corp. |
Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
|
JP6411491B2
(ja)
*
|
2013-07-12 |
2018-10-24 |
ギリアード サイエンシス インコーポレーテッド |
多環式カルバモイルピリドン化合物およびhiv感染症を処置するためのその使用
|
NO2865735T3
(me)
*
|
2013-07-12 |
2018-07-21 |
|
|
WO2015039348A1
(en)
*
|
2013-09-23 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
|
AU2014324829B2
(en)
|
2013-09-27 |
2017-09-07 |
Merck Sharp & Dohme Corp. |
Substituted Quinolizine Derivatives useful as HIV integrase inhibitors
|
US20150146340A1
(en)
|
2013-11-26 |
2015-05-28 |
Qualcomm Incorporated |
Multilayer ceramic capacitor including at least one slot
|
WO2015089847A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Spirocyclic heterocycle compounds useful as hiv integrase inhibitors
|
US9856271B2
(en)
|
2014-01-21 |
2018-01-02 |
Laurus Labs Limited |
Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
|